ABVC BioPharma (ABVC)

• Market cap: $53.2M
• 1 day: 7.35%
• 5 days: 3.79%
• 1 month: -19.49%
• 3 months: -22.89%
• 6 months: 19.02%
• Year to date: 241.49%
• 1 year: 323.02%
• 5 years: -92.68%
• 10 years: -92.68%
• Sector: Healthcare
• Industry: Biotechnology

About: ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Employees: 19